These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 4746740)

  • 1. Dopamine release and direct dopamine receptor activation in the central nervous system by D-145, an amantadine derivative.
    Svensson TH
    Eur J Pharmacol; 1973 Sep; 23(3):232-8. PubMed ID: 4746740
    [No Abstract]   [Full Text] [Related]  

  • 2. [The functional role of amantadine].
    Strömberg U; Svensson T
    Lakartidningen; 1972 Nov; 69(46):5340-2. PubMed ID: 4650742
    [No Abstract]   [Full Text] [Related]  

  • 3. Further studies on the mode of action of amantadine.
    Strömberg U; Svensson TH
    Acta Pharmacol Toxicol (Copenh); 1971; 30(3):161-71. PubMed ID: 5171936
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of scopolamine on the cerebral accumulation of 14 C-catecholamines from 14 C-tyrosine.
    Hitzemann RJ; Loh HH; Domino EF
    Pharmacology; 1972; 8(4):291-9. PubMed ID: 4657977
    [No Abstract]   [Full Text] [Related]  

  • 5. Turning behavior of mice with unilateral 6-hydroxydopamine lesions in the striatum: effects of apomorphine, L-DOPA, amanthadine, amphetamine and other psychomotor stimulants.
    Von Voigtlander PF; Moore KE
    Neuropharmacology; 1973 May; 12(5):451-62. PubMed ID: 4145343
    [No Abstract]   [Full Text] [Related]  

  • 6. Dopamine and noradrenaline releasing action of amantadine in the central and peripheral nervous system: a possible mode of action in Parkinson's disease.
    Farnebo LO; Fuxe K; Goldstein M; Hamberger B; Ungerstedt U
    Eur J Pharmacol; 1971 Sep; 16(1):27-38. PubMed ID: 5157529
    [No Abstract]   [Full Text] [Related]  

  • 7. Production of ( 3 H)catecholamines in the brain following the peripheal administration of 3 H-dopa during pre- and postnatal development.
    Kellogg C; Lundborg P
    Brain Res; 1972 Jan; 36(2):333-42. PubMed ID: 5061894
    [No Abstract]   [Full Text] [Related]  

  • 8. Catalepsy, sedation and hypothermia induced by alpha-methyl-p-tyrosine in the rat. An ideal tool for screening of drugs active on central catecholaminergic receptors.
    Papeschi R; Randrup A
    Pharmakopsychiatr Neuropsychopharmakol; 1973 May; 6(3):137-57. PubMed ID: 4800160
    [No Abstract]   [Full Text] [Related]  

  • 9. Adrenergic receptor blocking agents: effects on central noradrenaline and dopamine receptors and on motor activity.
    Andén NE; Strömbom U
    Psychopharmacologia; 1974; 38(2):91-103. PubMed ID: 4533319
    [No Abstract]   [Full Text] [Related]  

  • 10. Alteration of central catecholamine metabolism following acute administration of ethanol.
    Liljequist S; Carlsson A
    J Pharm Pharmacol; 1978 Nov; 30(11):728-30. PubMed ID: 31442
    [No Abstract]   [Full Text] [Related]  

  • 11. Behavioural and biochemical interaction between caffeine and L-dopa.
    Strömberg U; Waldeck B
    J Pharm Pharmacol; 1973 Apr; 25(4):302-8. PubMed ID: 4146682
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of amantadine on radiolabeled biogenic amines in the rat brain.
    Symchowicz S; Korduba CA; Veals J
    Eur J Pharmacol; 1973 Feb; 21(2):155-60. PubMed ID: 4696098
    [No Abstract]   [Full Text] [Related]  

  • 13. Receptor activity and turnover of dopamine and noradrenaline after neuroleptics.
    Andén NE; Butcher SG; Corrodi H; Fuxe K; Ungerstedt U
    Eur J Pharmacol; 1970; 11(3):303-14. PubMed ID: 5477307
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of 3H-dopa for studying cerebral catecholamine metabolism.
    Persson T; Waldeck B
    Acta Pharmacol Toxicol (Copenh); 1968; 26(4):363-72. PubMed ID: 5755483
    [No Abstract]   [Full Text] [Related]  

  • 15. Amantadine may stimulate dopamine and noradrenaline receptors.
    Papeschi R
    Neuropharmacology; 1974 Jan; 13(1):77-83. PubMed ID: 4522901
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of phencyclidine on the accumulation of 14 C-catecholamines formed from 14 C-tyrosine.
    Hitzemann RJ; Loh HH; Domino EF
    Arch Int Pharmacodyn Ther; 1973 Apr; 202(2):252-8. PubMed ID: 4694363
    [No Abstract]   [Full Text] [Related]  

  • 17. On the mode of action of amantadine.
    Stromberg U; Svensson TH; Waldeck B
    J Pharm Pharmacol; 1970 Dec; 22(12):959-62. PubMed ID: 4395528
    [No Abstract]   [Full Text] [Related]  

  • 18. Central actions of dopa and dopamine.
    Sourkes TL
    Rev Can Biol; 1972; 31():Suppl:153-68. PubMed ID: 4403289
    [No Abstract]   [Full Text] [Related]  

  • 19. The anti-parkinsonian drug amantadine inhibits the N-methyl-D-aspartic acid-evoked release of acetylcholine from rat neostriatum in a non-competitive way.
    Stoof JC; Booij J; Drukarch B; Wolters EC
    Eur J Pharmacol; 1992 Mar; 213(3):439-43. PubMed ID: 1618282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a central noradrenaline receptor stimulation by clonidine.
    Andén NE; Corrodi H; Fuxe K; Hökfelt B; Hökfelt T; Rydin C; Svensson T
    Life Sci; 1970 May; 9(9):513-23. PubMed ID: 4393798
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.